Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo

Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo

Objective: Human Pygopus 2 (Pygo2) was recently discovered to be a component of the Wnt signaling pathway required for β-catenin/Tcf-mediated transcription. But the role of Pygo2 in malignant cell proliferation and invasion has not yet been determined. Methods: Lentivirus-mediated small interfering...

Full description

Bibliographic Details
Main Authors:	Rongfu Liu, Xiangcheng Qin, Chengyong Ji, Weixin Zeng, Yufeng Yang, Wei Tan
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	Asian Journal of Urology
Subjects:	Pygo2 Renal cell carcinoma Matrix metalloproteinase-7 Matrix metalloproteinase-9 Vascular endothelial growth factor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388215000831

Similar Items

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy
by: Jian Hua Qi, et al.
Published: (2022-11-01)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
by: Ya-Tang Chiang, et al.
Published: (2023-01-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
by: Hao Huang
Published: (2018-09-01)

Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients
by: Ekaterina A. Korotkova, et al.
Published: (2023-05-01)

Influence of diuretics with antialdosterone effect on the condition of extracellular matrix and early postinfarction remodeling of the left ventricle in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2015-08-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Neuroprotective Effects of Chlorogenic Acid in a Mouse Model of Intracerebral Hemorrhage Associated with Reduced Extracellular Matrix Metalloproteinase Inducer
by: Yang Liu, et al.
Published: (2022-07-01)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
by: Shinji Takai, et al.
Published: (2022-10-01)

Diagnostic value of matrix metalloproteinase-9 in the course of osteoarthritis in young persons with excessive body weight and obesity
by: A. Litvynova, et al.
Published: (2022-06-01)

MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation
by: Yu-Chung Shih, et al.
Published: (2021-05-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer
by: F.C. Jobim, et al.
Published: (2009-10-01)

Activity of matrix metalloproteinase type 9 and its relationship with calcification of the thoracic aorta in patients with resistant hypertension: cross-sectional comparative study
by: Marina S. Litvinova, et al.
Published: (2023-04-01)

A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis
by: Fatemeh Ghasemi Sakha, et al.
Published: (2020-06-01)

MMPs and TIMPs Expression Levels in the Periodontal Ligament during Orthodontic Tooth Movement: A Systematic Review of In Vitro and In Vivo Studies
by: Christian Behm, et al.
Published: (2021-06-01)

Comprehensive Analysis of the Role of Gene Variants in Matrix Metalloproteinases and Their Tissue Inhibitors in Retinopathy of Prematurity: A Study in the Polish Population
by: Aneta Choręziak-Michalak, et al.
Published: (2023-10-01)

Production of factors involved into fibrosis regulation by various types of human macrophages
by: A. A. Maksimova, et al.
Published: (2020-08-01)

The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms
by: Miłosz Caban, et al.
Published: (2022-04-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications
by: Beata Gajewska, et al.
Published: (2022-09-01)

Short term effect of tetrahydrocurcumin on adipose angiogenesis in very high-fat diet-induced obesity mouse model
by: Bhornprom Yoysungnoen, et al.
Published: (2023-10-01)

MMP-13, VEGF, and Disease Activity in a Cohort of Rheumatoid Arthritis Patients
by: Mihail Virgil Boldeanu, et al.
Published: (2023-05-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Dynamics of Matrix Metalloproteinases in Local Cold Injury
by: M. I. Mikhailichenko, et al.
Published: (2019-11-01)

Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer
by: F Reichenberger, et al.
Published: (2001-05-01)

Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus
by: Alan Uriel García-Tejeda, et al.
Published: (2018-12-01)

Effect of microRNA-21 on the proliferation of human degenerated nucleus pulposus by targeting programmed cell death 4
by: B. Chen, et al.
Published: (2016-05-01)

The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
by: Zhenshengnan Li, et al.
Published: (2023-04-01)

Updating the role of matrix metalloproteinases in mineralized tissue and related diseases
by: Cintia Kazuko Tokuhara, et al.

The Effect of AdipoRon on the Activity of Caspase 3, Matrix Metalloproteinases 2 and 9, and Angiogenesis in Rat Bone Marrow-Derived Mesenchymal Stem Cell
by: Sara Malih, et al.
Published: (2018-04-01)

Significance of matrix metalloproteinase-9 expression in the ectopic endometrial tissue of women with endometriosis
by: Ashraf M Kansouh, et al.
Published: (2019-01-01)

The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
by: Yuling Wang, et al.
Published: (2024-02-01)